
Professor Kathreena Kurian
BSc, MBBS, MD, FRCPATH (Neuro)
Current positions
Professor of Neuropathology
Bristol Medical School (PHS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
Professor Kathreena Kurian runs the Brain Tumour Research Centre, Bristol Medical School, University of Bristol.
She is a Professor of Neuropathology and Honorary Consultant at Southmead Hospital, North Bristol Trust and runs the NIHR portfolio IVMT cohort study.
She undertook medical training in Guy’s and St Thomas’ Hospital Medical School, London where she also achieved a BSc in Experimental Pathology. She undertook higher pathology and neuropathology clinical (FRCPath Neuro) and research training including an MD (Medical Faculty Research Fellowship) in Edinburgh and Cambridge.
She is Chair of the British Neuropathological Society Clinical Practice Committee.
She sits on the National Cancer Research Institute, Brain Tumour Group and Tessa Jowell Cancer mission.
She is on the Board of Trustees for the Science Centre We the Curious.
Projects and supervisions
Publications
Selected publications
14/03/2014Biological Rationale for the Use of PPAR Agonists in Glioblastoma
Frontiers in Oncology
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner
Genes & development
IDH mutation analysis in gliomas as a diagnostic and prognostic biomarker
British Journal of Neurosurgery
Recent publications
16/09/2023GENOMIC LANDSCAPE AND ACTIONABLE MUTATIONS OF BRAIN METASTASES IN NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW
Insulin-like growth factor binding protein-2 and glucose-regulated protein 78kDa
Cancer Medicine
Multicolor Photoluminescent Carbon Dots à La Carte for Biomedical Applications
ACS Applied Materials & Interfaces
Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker
Journal of Personalized Medicine
Role of DNA methylation in the relationship between glioma risk factors and glioma incidence
Scientific Reports